Clinical Trial Update: Dexmedetomidine and Subarachnoid Haemorrhage [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating dexmedetomidine for subarachnoid hemorrhage has completed, conducted at Turku University Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysm
• Subarachnoid Hemorrhage

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Turku University Hospital | Conditions: Subarachnoid Hemorrhage, Aneurysm | Phase 1, Phase 2 | Status: COMPLETED